Disitamab vedotin shows phase 3 benefit in HER2-positive breast cancer liver metastases
In a finding that could reshape the treatment landscape for one of the most difficult scenarios in breast cancer care, ...
In a finding that could reshape the treatment landscape for one of the most difficult scenarios in breast cancer care, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine